Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Cardiovascular Electrophysiology|June 30, 2026
Pulsed Field Ablation Is Associated With Fewer Post-Procedural Pericardial Inflammatory Symptoms Compared With Radiofrequency AblationDor Yadin, Michael Barkagan, Maxime Zabern, et al.
JACC. Clinical Electrophysiology|August 8, 2026
Atrial Fibrillation Initiation Arises From Reentry at Patient-Specific Regions With Steep Repolarization Gradients Identified During Sinus RhythmElad Anter, Michael Barkagan, Dor Yadin, et al.
Frontiers in Pharmacology|February 4, 2020
The Hyperpolarization-Activated Cyclic-Nucleotide-Gated Channel Blocker Ivabradine Does Not Prevent Arrhythmias in Catecholaminergic Polymorphic Ventricular TachycardiaHanna Bueno-Levy, David Weisbrod, Dor Yadin, et al.
Heart Rhythm|March 25, 2017
Viral delivered gene therapy to treat catecholaminergic polymorphic ventricular tachycardia (CPVT2) in mouse modelsEfrat Kurtzwald-Josefson, Dor Yadin, Shiraz Harun-Khun, et al.
JACC. Clinical Electrophysiology|March 27, 2025
Optimizing Interelectrode Distance for Accurate Mapping of Postinfarct Scars: Insights on Electrogram CharacteristicsMichael Barkagan, Ofir Brem, Arwa Younis, et al.
Biochemical Pharmacology|August 12, 2023
Effect of pharmacological heart failure drugs and gene therapy on Danon's cardiomyopathyDor Yadin, Tali Guetta, Zachary Petrover, et al.
Biochemical Pharmacology|August 26, 2022
Autophagy guided interventions to modify the cardiac phenotype of Danon diseaseDor Yadin, Zachary Petrover, Asher Shainberg, et al.
Cardiovascular Diabetology|August 4, 2018
Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving 'SIRT1 and PGC-1α'Maayan Waldman, Keren Cohen, Dor Yadin, et al.
Cardiovascular Diabetology|August 19, 2018
Correction to: Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving 'SIRT1 and PGC-1α'Maayan Waldman, Keren Cohen, Dor Yadin, et al.
EMBO Molecular Medicine|February 22, 2017
SK4 K+ channels are therapeutic targets for the treatment of cardiac arrhythmiasShiraz Haron-Khun, David Weisbrod, Hanna Bueno, et al.
Pageof 2